Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Intravenous vitamin C can improve anemia in erythropoietin-hyporesponsive hemodialysis patients

Nature Clinical Practice Nephrology volume 2, pages 552–553 (2006)Cite this article

boxed-textAttallah N et al. (2006) Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Am J Kidney Dis 47: 644–654

Intravenous vitamin C effectively corrects erythropoietin hyporesponsiveness in dialysis patients with hyperferritinemia, but regular plasma oxalate monitoring is needed to prevent oxalate overload

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Tarng DC et al. (2001) Erythropoietin and iron: the role of ascorbic acid. Nephrol Dial Transplant 16 (Suppl 5): 35–39

    Article  CAS  Google Scholar 

  2. Tarng DC et al. (1999) Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. Kidney Int 55: 2477–2486

    Article  CAS  Google Scholar 

  3. Keven K et al. (2003) Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients. Am J Kidney Dis 41: 1233–1239

    Article  CAS  Google Scholar 

  4. Canavese C et al. (2005) Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients. Am J Kidney Dis 45: 540–549

    Article  CAS  Google Scholar 

  5. Hoen B et al. (2002) Intravenous iron administration does not significantly increase the risk of bacteremia in chronic hemodialysis patients. Clin Nephrol 57: 457–461

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Emeritus Professor of Nephrology at the Pitié-Salpêtrière Medical School in Paris, France

    Claude Jacobs

Authors
  1. Claude Jacobs
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claude Jacobs.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jacobs, C. Intravenous vitamin C can improve anemia in erythropoietin-hyporesponsive hemodialysis patients. Nat Rev Nephrol 2, 552–553 (2006). https://doi.org/10.1038/ncpneph0281

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0281

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing